Author:
Vulpis Vito,Seccia Teresa M.,Ricci Serafina,Nazzaro Pietro,Pirrelli Anna
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference6 articles.
1. Zachariah PK, Sheps SG, Schriger A. Efficacy of sustained-release verapamil: Automatic ambulatory blood pressure monitoring.J Clin Hypertens 1986;3:133S-142S.
2. Hla KK, Henry JA, Latham AN. Pharmacokinetics and pharmacodynamics of two formulations of verapamil.Br J Clin Pharmac 1987;24:661?664.
3. McMahon FG, Reder RF. The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension.J Clin Pharmacol 1989;29:1003?1007.
4. MacGregor GA. A randomised dose study of verapamil in patients with essential hypertension. In: Althaus U, Burckhardt D, Vogt E, eds.Calcium Antagonismus Internat.Symposium on Calcium-Antagonism. Frankfurt/Main: Verlag GmbH, 1984:125?126.
5. Antonicelli R, Tomassini PF, Galletti P, et al. Age-related antihypertensive and haemodynamic effects of verapamil SR: Clinical results and effects on atrial natriuretic peptide.Eur J Clin Pharmacol 1990;39(Suppl 1):S29-S33.